The European Commission intends to approach Pfizer/BioNTech for the advance purchase of vaccines. “We are almost there”, a European official said on Thursday 3 September, after the United States and the United Kingdom both placed orders with the alliance between the US laboratory and the German biotech company.
At this stage, the European Commission has reached an agreement with AstraZeneca for the advance purchase of its candidate vaccine, which could reach the European market as...